7. In a recent set of two articles on treatment for smoking cessation published in the Annals of Behavioral Medicine in April 2011 (; ), the conflict of interest statement regarding Dr. Fiore acknowledges that: "Over the last 3 years, Michael C. Fiore served as an investigator on research studies at the University of Wisconsin that were funded by Nabi Biopharmaceuticals."

For example, Stan Glantz argued against electronic cigarettes in a Scientific American , claiming that: "We’ve found very high levels of dual use [traditional cigarettes along with e-cigarette use]. Very few people have switched away from cigarettes or managed to use them as a bridge to eventually go off cigarettes."

Ironically, in the long run, hiding the influence of Big Pharma on smoking cessation policy does not advance the cessation field, but brings it to a grinding halt. The public, and tobacco control practitioners themselves, need to understand the deeply ingrained roots of Big Pharma within the tobacco control movement, especially in the smoking cessation field. Failure to do so will lead to blind following of an industry-based agenda. This is precisely what has happened in tobacco control.

LAST：Best selling e-cigarette e mix exgo w2 electronic cigarette ecig exgo E-MIX-A1 yocan exgo 510 |NEXT：Rectangle Igo Vaporizer Wholesale Igo Vaporizer